Thrombocytopenia: Clinicobiologic validation and classification;Validation et classification clinicobiologique d'une thrombopénie

Annales de Biologie Clinique

Volumn 63, Issue 6, 2005, Pages 599-610

  Latger Cannard, V ^a   Salignac, S ^a   Salmon, A ^a   Mansuy, L ^a   De Maistre, E ^a   Botte, C ^a   Bordigoni, P ^a   Schlegel, N ^b   Lecompte, T ^a  

^a UNIVERSITY HOSPITAL OF NANCY   (France)

^b HÔPITAL ROBERT DEBRÉ   (France)

Author keywords

Immune thrombocytopenic purpura; Inherited thrombocytopenia; Large platelet; Thrombocytopenia

Indexed keywords

BLOOD; CASE REPORT; CLASSIFICATION; FEMALE; HUMAN; INFANT; REVIEW; THROMBOCYTOPENIA;

FEMALE; HUMANS; INFANT; THROMBOCYTOPENIA;

EID: 29544451733     PISSN: 00033898     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (22)

1. Harrison P. Progress in the assessment of platelet function. Br J Haematol 2000 ; 111 : 733-44.
2. Harrison P, Horton A, Grant D, Briggs C, Machin S. Immunoplatelet counting a proposed new reference procedure. Br J Haematol 2000 ; 108 : 228-35.
3. Kuntz D, Höffkes HG, Kuntz WS, Gressner AM. Standardized flow cytometric method for the accurate determination of platelet counts in patients with severe thrombocytopenia. Cytometry 2000 ; 42 : 284-9.
4. Norris S, Pantelidou D, Smith D, Murphy M. Immunoplatelet counting : potential for reducing the use of platelet transfusions through more accurate platelet counting. Br J Haematol 2003 ; 121 : 605-13.
5. Drachman J. Inherited thrombocytopenia : when a low platelet count does not mean ITP. Blood 2004 ; 103 : 390-8.
6. Trichet C, Beauchamp-Nicoud A, Proulle V, Bader-Meunier B, Tchernia G, Dreyfus M. Les thrombopénies constitutionnelles : de la clinique à la biologie. Hématologie 2003 ; 9 : 439-55.
7. Imai K, Morio T, Zhu Y, et al. Clinical course of patients with WASP gene mutations. Blood 2004 ; 15 : 456-64.
8. Jin Y, Mazza C, Christie JR, et al. Mutations of the Wiskott-Aldrich Syndrome Protein (WASP) : hot spots, effect on transcription and translation and phenotype/genotype correlation. Blood 2004 ; 104 : 4010-9.
9. Rengan R, Ochs HD. Molecular biology of the Wiskott-Aldrich syndrome. Rev Immunogenet 2000 ; 2 : 243-55.
10. van den Oudenrijn S, Bruin M, Folman CC, et al. Mutations in the thrombopoietin receptor, Mpl, in children with congenital amegakaryocytic thrombocytopenia. Br J Haematol 2000 ; 110 : 441-8.
11. Drachman JG, Jarvik GP, Mehaffey MG. Autosomal dominant thrombocytopenia : incomplete megakaryocyte differentiation and linkage to human chromosome 10. Blood 2000 ; 96 : 118-25.
12. Michaud J, Wu F, Osato M, et al. In vitro analyses of known and novel RUNX1/AML1 mutations in dominant familial platelet disorder with predisposition to acute myelogenous leukemia : implications for mechanisms of pathogenesis. Blood 2002 ; 99 : 1364-72.
13. Letestu R, Vitrat N, Masse A, et al. Existence of a differentiation blockage at the stage of a megakaryocyte precursor in the thrombocytopenia and absent radii (TAR) syndrome. Blood 2000 ; 95 : 1633-41.
14. Thompson AA, Woodruff K, Feig SA, Nguyen LT, Schanen NC. Congenital thrombocytopenia and radio-ulnar synostosis : a new familial syndrome. Br J Haematol 2001 ; 113 : 866-70.
15. Kahr WH, Zheng S, Sheth PM, et al. Platelets from patients with the Quebec platelet disorder contain and secrete abnormal amounts of urokinase-type plasminogen activator. Blood 2001 ; 98 : 257-65.
16. Latger-Cannard V, Bensoussan D, Gregoire MJ, et al. Frequency of thrombocytopenia and large platelets correlates neither with conotruncal cardiac anomalies nor immunological features in the chromosome 22q11.2 deletion syndrome. Eur J Pediatr 2004 ; 163 : 327-8.
17. Kato T, Kosaka K, Kimura M, et al. Thrombocytopenia in patients with 22q11.2 deletion syndrome and its association with glycoprotein Ibβ. Genet Med 2003 ; 5 : 113-9.
18. Lawrence S, McDonald-McGinn DM, Zackai E, Sullivan K. Thrombocytopenia in patients with chromosome 22q11.2 deletion syndrome. J Pediatr 2003 ; 143 : 277-8.
19. Favier R, Jondeau K, Boutard P, et al. Paris-Trousseau syndrome : clinical, hematological, molecular data of ten new cases. Thromb Haemost 2003 ; 90 : 893-7.
20. Raslova H, Komura E, Le Couedic JP, et al. FLI1 monoallelic expression combined with its hemizygous loss underlies Paris-Trousseau/Jacobsen thrombopenia. J Clin Invest 2004 ; 114 : 77-84.
21. Mehaffey M, Newton A, Gandhi M, Crossley M, Drachman J. X-linked thrombocytopenia caused by a novel mutation of GATA-1. Blood 2001 ; 98 : 2681-8.
22. Freson K, Devriendt K, Van Hoof A, et al. Platelet characteristics in patients with X-linked macrothombocytopenia because of a novel GATA1 mutation. Blood 2001 ; 98 : 85-92.